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Why has the authorization of microbial
biological control agents been slower in the
EU than in comparable jurisdictions?
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Abstract
The aim of this study was to identify reasons why the authorization of microbial pest control agents is lengthier under regulatory
frameworks of theEuropeanUnion (EU) than in comparable jurisdictions. Amain conclusion is that although the EUʼs regulatorypro-
cesses have strong scientific foundations, themost appropriate scientific concepts, knowledge and expertise have not been applied
in the safety assessment of microorganisms and biological control. Tradition and conceptual legacies from assessments of conven-
tional chemicalpesticideshave likely contributed to thisby steering theevaluationsofmicroorganisms in less appropriatedirections.
According to our investigation, the current framework for microbial plant protection products complies poorly with the principles
that legislation should have legal predictability, proportionality, and that it shouldbenon-discriminative, for instance in comparison
to corresponding regulations in comparable jurisdictions.Wealso found that existingpossibilities to takenon-safety andethical con-
siderations into account can probably be used more. To rationalize the EUʼs authorization of microbial control products, both the
basic legislation and the evaluations of agents and products need stronger rooting in fundamental microbiological science.
© 2020 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Supporting information may be found in the online version of this article.
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1 INTRODUCTION: THE NEED TO EXPAND
USE OF MICROBIAL PEST AND DISEASE
CONTROL
With anticipated increases in the human global population, the pro-
tection of food crops from pests (including plant diseases) is likely to
be a high priority for the foreseeable future. Accordingly, the United
Nations declared 2020 as the International Year of Plant Health
(http://www.fao.org/3/ca0324en/CA0324EN.pdf). The dependence
on conventional chemical active substances for crop protection that
has prevailed since themiddle of the 20th century is now challenged
by ambitions to increase use of alternative crop protectionmeasures
with less adverse side effects on humans and the environment. In
the European Union (EU), the sustainable pesticide use Directive1
stated that by 2014 all EU countries should have implemented inte-
grated pest management (IPM), in which alternative approaches not
involving application of conventional chemical active substances
should be the first choices, if available. Stricter legislation has led to
withdrawal from the market of many chemical pesticides that do
not meet current safety standards, adding to a shortage of available
control solutions to farmers.2,3 One alternative approach is biological
control, where ‘natural enemies’ are used to control pest organisms.
Antagonistic or insect pathogenic microorganisms (fungi, bacteria,
viruses and other), insect parasitic nematodes, and arthropod preda-
tors and parasitoids, have all been successfully applied in biological
control.4 Moreover, new microbial strains that are promising biolog-
ical control agents are continuously being isolated and
characterized.5
A report from the EU Parliament expressed concern over poor imple-
mentation of the provisions of the sustainable pesticide use Directive
and of IPM, and concluded that little progress has been made in pro-
motingalternative techniques.6However, in the ‘FarmtoFork Strategy’,7
theEUCommission recently identifiedactions to furtherpromoteuseof
alternative approaches for crop protection and facilitate the placing of
products containing biological active substances on the market.
2 THE PROBLEM: SLOW
IMPLEMENTATION OF MICROBIAL
CONTROL
In many jurisdictions, rules concerning microbial pest control
agents (MCAs) and products have been incorporated in the regu-
latory framework covering production and use of pesticides.8,9
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Regulatory provisions for MCAs is a global phenomenon, and not
restricted to Western countries or any particular geographic
region.8 In the EU, MCAs are categorized either as plant protection
products (PPPs) or biocides (all pesticides that are not PPPs). Thus,
they are approved (active agents) and authorized (formulated
products) according to the systems initially developed for chemi-
cal pesticides (see Table 1 for basic features of the regulatory pro-
cess). Our focus is on the regulation of PPPs, but many of the
issues and principles we address are also relevant for the regula-
tion of microbial biocides.
From a societal policy perspective, regulatory measures for any
products should be tailored to the specific potential hazards and
risks they pose. Unnecessarily strict regulations can discourage
innovation, retard scientific and technological progress,19,20 and
lead to waste of resources.21 In contrast, excessively permissive
policy can leave the public and environment exposed to unpre-
dictable, potentially severe, risks.
Many studies published in recent decades have stressed that
regulatory frameworks for MCAs have been significant barriers
to the implementation of microbial control of pests in
practice.22-28 Moreover, the average time for authorization of
an MCA-product has been substantially longer in the EU than
in comparable jurisdictions.13,15,24 Recent studies have con-
firmed that the EU is lagging behind other countries when it
comes to practical implementation of MCAs, and that this is
due to the complex and lengthy authorization processes.16,29
This implies that suboptimal regulatory frameworks have slo-
wed transition towards IPM in pest management and regulation
of pest populations through exploitation of ecological interac-
tions between pests and their natural enemies.23,30,31 It has
been shown that the performance of approval processes can
have strong effects on the economic incentives to make invest-
ments in new technologies and products.32 Thus, improved
authorization processes for MCAs in the EU are likely to have a
positive impact on investments and market release of new
MCA-products.
3 OBJECTIVES AND OUTLINE
The objectives of this study are to:




Before the beginning of the 1990s, any regulation of MCAs for plant
protection was under national oversight and regulatory policies
differed among countries. This situation changed with the
introduction of the common European regulation for plant
protection products (Directive 91/414). Directive 91/414 was
subsequently replaced by Regulation 1107/2009. Several review
articles provide further details on the historical developments of
regulatory policies for MCAs.
Quinlan 199010
EU 199111 (first common EU regulation of PPPs)
EU 200912 (Regulation 1107/2009 for PPPs)
Ravensberg 2011,13 Sundh & Goettel 201314 (historical




Microbial PPPs are registered in EU in two steps: (i) the so-called ‘active
substance’ (i.e. the microorganism) is approved at EU level; and (ii)
formulated products are authorized at member state level. Note
than even though an MCA is a live, biological entity, it is referred to
as a ‘substance’, in line with the terminology for pesticides.
The basic criteria for evaluating MCAs and their corresponding
formulated products are that they should be: (i) safe (for the human
public and the environment); and (ii) efficacious.
Hauschild et al. 2011,15 Frederiks & Wesseler 201916





An ‘active substance’ of a PPP can be either a ‘chemical’ or a
‘microorganism’. Microorganisms include bacteria, fungi,
protozoans, viruses and viroids. The chemicals category of PPPs
includes, apart from traditional chemical actives, semiochemicals
and other biologically produced compounds, and extracts from
plants or other organisms.
Although they are categorized as chemical active










The same framework and procedures as for chemical PPPs
(overarching Regulation 1107/2009) are applied. However, specific
data requirements (Directive 2001/36) and uniform evaluation
principles (Directive 2005/25) for microbial agents and products
have been developed. These define the information that has to be
provided with the application dossier, thus defining the topics that
will form the basis for the risk assessment.
EU 200117 (data requirements microbial PPPs)
EU 200518 (uniform evaluation principles microbial
PPPs)
For the purpose of legal and administrative
adjustments to the updated PPP regulation
(1107/2009), the data requirements and uniform
principles were subsequently re-published (but not
updated) together with the corresponding
requirements for chemicals in Regulation
283/284/2013 and Regulation 546/2011,
respectively.
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• Briefly consider what can reasonably be expected from a scien-
tific and a legal perspective of regulatory frameworks for MCAs.
• Identify attributes of the regulatory frameworks that might
have contributed to the slower uptake of MCAs in the EU than
in other jurisdictions.
• Recommend actions that may lead to simpler andmore appro-
priate evaluation processes in the future.
We examined the functionality of the current regulatory system
according to three categories of principles and criteria (adapted
from Zetterberg & Edvardsson Björnberg 201733). The first is the
suitability of the current regulatory frameworkʼs scientific founda-
tions in terms of relevance and utility for assessing the safety of
microbial pest and disease control measures and in terms of sci-
entific adaptability, i.e. the ability to adjust the regulations in
accordance with scientific progress and developments.20,34
The second category of principles includes legal certainty, non-
discrimination and proportionality. Legal certainty refers to regu-
lations' precision and understandability of both their clauses and
the clauses' implications, especially for those to whom they apply.
According to the principle of non-discrimination like risks should
be treated alike,35 i.e. a regulatory policy should not favor or disfa-
vor any type of products over others that pose similar risks, with-
out sound, explicit reasons. According to the principle of
proportionality, governmental regulatory measures (for protect-
ing humans or the environment) should be effective, necessary
and balanced,36 i.e. they should serve public interests and not
be replaceable by equally effective but less intrusive measures.
These three factors (legal certainty, non-discrimination and pro-
portionality) partly overlap and should not be considered in
isolation.33
The third category of principles concerns the extent that current
frameworks allow non-safety and ethical considerations. Here we
addressed the role of the efficacy requirement for authorization of
new microbial products. We also examined whether the frame-
work leaves room for considering sustainability arguments
(e.g. that MCAs may be less harmful to humans and the environ-
ment than chemicals they can replace) and socio-economic
benefits.
Procedural and bureaucratic factors can also have impacts on
the performance of the evaluation and authorization processes.
For instance, in contrast to the EU, in the USA MCAs are evaluated
by a dedicated unit for evaluations of ‘biopesticides’, but still
under the general pesticide regulatory framework (FIFRA). How-
ever, such procedural factors are not the subject of this study.




4.1.1 Relevance of the science
For several decades, the legal frameworks and evaluations of
MCAs in the EU and USA have been recurrently criticized for plac-
ing too much emphasis on chemical toxicology and ecotoxicol-
ogy, and hence chemical risks, rather than the biological and
ecological properties and specific potential risks associated with
microorganisms.13,14,25,27,29,37–43 For example, a review published
40 years ago of the first, national registration in Europe (France)
during the 1970s of an MCA against plant diseases included the
following comment: ‘However, a major problem is that existing
rules were designed for new chemical compounds, not
microorganisms, so that a granting of a sales permit calls for a
rational interpretation of these rules by competent authorities’.37
Remarkably, today, after implementation in the early 1990s of
Directive 91/414 for PPPs (the first EU-wide framework to include
both chemical active substances and microorganisms), the EUʼs
process for evaluating MCAs is still not well adapted for microor-
ganisms.42,43 However, since control of MCAs was incorporated
into a new, precautionary framework intended to cover risks asso-
ciated with production and use of xenobiotic chemical pesticides,
it is perhaps not entirely surprising that this system has been sub-
optimal, or even poor, for evaluating potential risks associated
with living microorganisms.
Suboptimal legislation and evaluations of MCAs could conceiv-
ably have been due to generally low levels of scientific progress
and experience in microbiological safety assessment and biologi-
cal pest control. However, we find this explanation unlikely, since
the practical possibility of microbial pest control was established
in the first half of the 20th century, with the commercial introduc-
tion of products based on Bacillus thuringiensis against insects in
the 1930s.44 Moreover, by the beginning of the 1980s, the con-
cept of microbial control of both insects and plant diseases had
been developed and presented, together with well-reasoned
guidelines for risk analysis, safety testing and registration of bac-
terial MCAs.45–47 For example, in 1980 Burges ‘concluded that
the basis for risk analysis of pesticidal bacteria is now well
established’.45
Thus, we conclude that the problems in incorporating MCAs in
the EUʼs PPP regulations and subsequent development of spe-
cific regulatory documents for MCAs were not due to a general
lack of scientific knowledge. Instead it was due to a lack of suffi-
cient attention to available, relevant biological knowledge
regarding microbiological safety assessment and microbial pest
control.
The data requirements (DRs) and uniform evaluation principles
(UPs) regarding MCAs provide foundations and guidelines of the
EUʼs risk assessment regime and steer the risk assessors and eval-
uations to certain topics. However, although the legislation was
developed specifically for microorganisms, some of the require-
ments seem to have little relevance, or even be impossible to ful-
fill, for microorganisms.14,15,42,43 We also note that neither the DRs
nor the UPs treat MCAs as the live biological control agents they
are, but instead as ‘active substances’ of pesticides. Each docu-
ment mentions ‘biological control’ or ‘biocontrol’ only once, and
does not refer to the microorganisms actually evaluated as
biological control agents, but to potential negative effects of the
microbial PPP on any resident natural enemies exerting macro-
biological pest control. Thus, the current legislation appears to
promote a view that the potential risks of MCAs are best assessed
within a chemical paradigm.
The available resources and expertise of the agencies involved
influence the time it takes to complete an authorization process
for a new MCA.48 In the EU, responsibility for assessments of all
PPPs, chemical or microbiological, is allocated to the same regula-
tory institutions and units. Since chemical pesticides have domi-
nated the PPP market for decades, allocation of resources for
recruitment of microbiological expertise to assess the specific
potential risks posed by microorganisms may have been
neglected. Moreover, experience and expertise related to MCAs
can vary among the national authorities.49
We conclude that inadequate attention by the regulatory insti-
tutions to recruitment of microbiological expertise has likely con-
tributed to the EUʼs slower authorization of MCAs.
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4.1.2 Scientific adaptability
Regulatory systems should ideally have scientific adaptability,
i.e. ability to take new scientific and technical findings into
account.20,34 If new risks are identified, additional precautionary
measures may be needed. Conversely, if scientific progress shows
that suspected risks are unrealistic, regulatory demands can be
relaxed. Clearly, for example, as the EU currently includes 28mem-
ber-countries with potentially different views and priorities, the
PPP Regulation, DRs or UPs for evaluation are unlikely to be
updated particularly often. However, the DRs providing founda-
tions for the evaluations of MCAs were developed during the
1990s, as an Annex to the previous PPP Directive 91/414. Since
then there have been huge advances in understanding of the
phylogeny, ecology and molecular biology of microorganisms.
Thus, the regulations have not been aligned with current microbi-
ological knowledge. As an alternative to updating the basic legis-
lation, a more efficient strategy might be to produce and update,
on amore regular basis, documents providing guidance for apply-
ing the DRs and performing the assessments in practice. We note
that while the European Food Safety Authority (EFSA) supported
two systematic reviews on environmental and human safety
assessment of microbial PPPs,50,51 and regularly provide updated
guidance on various scientific aspects of risk assessment and
authorization of microorganisms in, for example, animal feed,52
and of chemical PPPs,53 EFSA do not develop guidance for evalu-
ations of microbial PPPs.
4.2 Legal certainty, non-discrimination and
proportionality
4.2.1 Legal certainty
According to the principle of legal certainty, a law should be
precise and understandable by those to whom it applies.
Factors that raise legal uncertainty include the long (in interna-
tional terms) and unpredictable registration times of MCAs in
the EU, which have putatively discouraged companies from reg-
istering their products for the EU market (presentation by
P. Marrone of Marrone Bio Innovations at Informa Ag-Bio
Congress in Amsterdam December 2015; IBMA White Paper54).
It should be noted that following introduction of the first
common EU regulation with Directive 91/414, the time required
for approval of an active agent gradually declined from 6–8 to
3.5–4 years.16 Increasing experience with evaluations of MCAs
at the regulatory institutions probably played a major role in
this reduction.15 However, the EU time spans still compare very
unfavorably with those in the USA, which were on average 1.5 to
2 years.16
Another uncertainty factor is the likelihood ofMCAs fulfilling the
criteria for low-risk category of PPPs introduced with regulation
1107/2009.12 This regulation stipulates that when an ‘active sub-
stance’ of a PPP meets certain criteria, it can be approved as a
low-risk substance, and thus approved for 15 years instead of
the normal 10 years, and that national product authorizations
should have a stricter timeline (at most 120 days). However, cri-
teria for categorizing active agents as low-risk were not published
until 2017,55 and practical guidance for interpreting the criterion
for microorganisms (that they should not have ‘multiple resis-
tance to anti-microbials used in human or veterinary medicine’)
was posted on the EU Commission website in November 2020.
Nevertheless, it is anticipated that most MCAs will comply with
these criteria and the EU Commission has published a list of MCAs
that are considered likely to become low-risk.56 While
implementation of the low-risk concept has been slow and unpre-
dictable to date, the assignment of MCAs to the low-risk category
should enable rationalization and acceleration of their registration
in the near future.
4.2.2 Non-discrimination
According to the principle of non-discrimination, like risks should
be treated alike. Since, globally, authorization of MCAs is often
incorporated in existing regulations of chemical pesticides,8,9 we
compared how some key aspects are treated in DRs of the EU
and other countries (Supporting Information, Supplementary
material S1). The comparison shows that some issues receive less
attention and/or are treated more straightforwardly in other
countries. A striking difference is in the attention to potential risks
posed by ‘metabolites’, a word mentioned 83 times in total in the
DRs and UPs of the EU, but only two, one and six times in corre-
sponding Australian, USA and Canadian documents, respectively
(Supporting Information, Supplementary material S1). It has been
noted that the remarkable emphasis on ‘metabolites’ in the EU
DRs is a legacy of the DRs for chemical PPPs, and that the DRs
for microorganisms mix up secondary metabolites produced by
microorganisms with degradation products (referred to as
‘metabolites’) of organo-chemical pesticides.43 This lack of clarity
in the DRs has probably contributed to complications and delays
in evaluations. This is because for regulatory experts familiar with
evaluating chemical PPPs, the word ‘metabolite’ (when used in
either context) may be a risk alert. This example shows that the
EU framework can be said to ‘discriminate’ more against MCAs
than the legislation of other countries.
4.2.3 Proportionality
According to the proportionality principle, regulatory measures
for MCAs should be reasonably aligned with those for other types
of microbes' applications in agriculture, food production and pro-
cessing, or the environment. However, comparative analyses have
demonstrated that regulations are substantially stricter for MCAs
than for non-MCA beneficial (non-genetically modified) microor-
ganisms used (for example) in plant growth stimulation, animal
feed additives, fermentation of foodstuffs, novel foods, or envi-
ronmental biotechnology, e.g. bioremediation).57 An overview of
other regulatory approaches taken for beneficial microorganisms
is given in Table 2.
A comparison with the EU policy for microorganisms that stim-
ulate plant growth and development by mechanisms other than
pest or disease control is particularly interesting. Currently, such
use of microorganisms is solely under national oversight within
the EU, and the regulations vary strongly among the member
states.61,62 This will change with implementation of the new com-
mon EU Regulation 2019/1009 for fertilisers,63 which includes pro-
visions for ‘biostimulants’, including the product function
category PFC 6A Microbial Plant Biostimulant (Supporting Infor-
mation, Supplementary material S2). Before the new system is
usable in practice, further guidance and criteria regarding the CE
marking of microbial biostimulants need to be developed. Never-
theless, the limited information requirements and absence of a
formal product authorization process for microbial biostimulants
in Regulation 2019/1009 (Supporting Information, Supplementary
material S2) is in contrast to the extensive DRs for MCAs of PPPs.
Moreover, a single microorganism (e.g. a strain of Bacillus or Tri-
choderma) may be capable of interacting with plants in several
ways, and organisms with pest or disease control and/or growth
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stimulation activities may be closely related.64,65 This supports the
view that the regulatory demands for MCAs in the EU are not pro-
portional to the actual risks, and thus that MCAs might be consid-
ered ‘overregulated’.
4.3 Inclusion of non-safety, ethical and socioeconomic
considerations
Apart from potential risks, the EU legislation and evaluations of
PPPs consider product efficacy, although it is evaluated during
Table 2. Overview of regulatory approaches for use of beneficial microorganisms in indicated sectors, relevant in view of the examination of the
regulatory framework for microbial plant protection products in the EU


















Regulation EC 429/2008 on rules for
implementation of 1831/2003, including DR
(https://eur-lex.europa.eu/legal-content/EN/TXT/
?qid=1551787483183&uri=CELEX:32008R0429).
The DRs for all types of feed additives are
given in Annexes to Regulation
429/2008.
Several guidance documents have been







(type of) food that













Regulation EU 2015/2283 on novel foods (https://
eur-lex.europa.eu/legal-content/EN/TXT/?qid=
1551790766574&uri=CELEX:32015R2283).
Implementing Regulation EU 2017/2469 with




EFSA has produced several guidance
documents concerning these
regulations, available at: (http://www.
efsa.europa.eu/en/applications/
nutrition/regulationsandguidance).
DRs for MO and other novel food
categories are given in a guidance
document by EFSA:
Guidance on the preparation and
presentation of an application for
authorization of a novel food in the
context of Regulation (EU) 2015/2283.
(http://www.efsa.europa.eu/en/
efsajournal/pub/4594).








The use of microorganisms in food fermentations
does not require authorization, as long as it is
considered as ‘traditional use’.
Regulatory aspects of food fermentations




Specific DRs for MO,
as for PPPs.




The DRs for MO in biocides are given in
Annex II in 528/2012.
A guidance document on microbial














- tolerance to abiotic
stress,
- crop quality




The new regulation stipulates that when
the MO and the corresponding product
fulfil two criteria, they can be added to a
positive list, obtain CE marking and then
be sold in the entire EU (see Suppl.
material 2). Pre-market authorization
not required.
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the national authorization of the formulated products. MCAs may
in some cases (but certainly not all) have lower efficacy than con-
ventional pesticides, but they have several other benefits related
to their potential replacement of more hazardous chemical pesti-
cides. For instance, long-term adverse effects in e.g. groundwater
or on human health due to persistence of harmful chemicals is not
a significant issue with MCAs. It has been calculated that biocon-
trol of a wireworm in maize production in six European countries
would provide an annual socioeconomic welfare gain, in mone-
tary terms, of €190 million.66 Another benefit of many MCAs is
that since their mode of action is more complex than that of a sin-
gle chemical, the targeted pests are less likely to evolve resistance
to them, and if resistance evolves it can be countered by using
other microbial strains.67,68 Current EU legislation enables consid-
eration of such benefits during the efficacy evaluation (see also
EPPO guidance on evaluation of microbial PPPs69) and an expert
group of the EU Council has proposed that for low-risk PPPs, such
as many MCAs, there is scope within IPM for taking such benefits
more into account.48 Similarly, one outcome of an OECD
workshop on strategies for implementation of IPM was a recom-
mendation that so-called ‘facilitative’ policies should play a signif-
icant role in the move towards more sustainable agriculture.70 We
strongly encourage such approaches, as laid out in two sets of
practical guidelines,71,72 since stronger emphasis on the potential
benefits of MCAs should further clarify their importance for the
transition towards IPM.
5 CONCLUSIONS AND RECOMMENDATIONS
• As a starting point for discussion, it may appear logical to
extend regulatory frameworks for pesticides to the regulation
of microorganisms for biological control of harmful organisms.
However, those frameworks were developed to address risks
posed by xenobiotic chemicals, and were strongly influenced
by tradition and conceptual legacies. Thus, they are unsuitable
for regulation of live microorganisms. The traditions and exper-
tise rooted in the science underlying the regulation of chemical
pesticides have steered the DRs and evaluations of MCAs in less
Table 2. Continued












Some countries have systems for authorization of
plant beneficial MO which are not classified as
PPPs, others have not.
Microbial biostimulants that have not
obtained CE marking according to the
new fertilizers regulation can still be
marketed in the EU, provided that any
national regulations are respected.
Overviews of regulations and DRs
in different countries are presented
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As an example, Sweden has an Environmental Act,
containing provisions for ‘Biotechnical
organisms’. These state that anyone importing,
producing, marketing or using a biotechnical
organism is responsible for the safety of the
operations. There are no actual data
requirements, since there is no requirement for
authorization.
MO, microorganism; DR, data requirement; EFSA, European Food Safety Authority; ECHA, European Chemicals Agency.
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appropriate directions, thereby contributing to confusing eval-
uations and retarding implementation of microbial pest control
in IPM, particularly in the EU.
• We have not found support for the idea that a general lack of
scientific knowledge and progress has contributed significantly
to the pesticide frameworks' functionality for authorization of
MCAs. Rather, relevant knowledge regarding biological pest
control, microbial ecology, and microbiological safety assess-
ment has been available for several decades, but has not been
sufficiently applied. Inexperience with MCAs and shortage of
microbiological expertise at regulatory institutions have proba-
bly contributed to lengthy and complicated evaluations.
We therefore emphasize that all responsible authorities
involved in MCA assessment must possess appropriate in-house
competence in microbiological sciences. For this, more resources
might have to be allocated for recruitment of personnel with
expertise in relevant aspects of microbiological sciences.
• Our investigation indicates that the amounts of resources,
including time, devoted to EU authorizations of MCAs are not
commensurate with the hazards associated with microorgan-
isms for humans or the environment, or with more pertinent
regulatory policies regarding their use in food, feed or other
types of environmental applications. Thus, MCAs exemplify
the principle that the primary focus of regulatory frameworks
for any organisms or substances of biological origin should be
on the intrinsic hazards and corresponding risks.
We therefore recommend that EU legislators intensify efforts to
formulate and implement more resource-efficient regulation of
MCAs, e.g. actions proposed in the Farm to Fork strategy. A
revised framework should be better tailored to the specific prop-
erties and hazards of microorganisms and less to traditions asso-
ciated with regulations of chemical pesticides. It should also be
helpful to increase the awareness of all involved institutions about
the undesirable consequences for evaluations of MCAs of the
‘chemical’ legacy of the PPP regulation, to avoid that such effects
unnecessarily complicate authorizations of MCAs in the future.
As long as MCAs are evaluated within the PPP framework in the
EU, we propose that the most strongly prioritized objectives
should be to: (i) develop more adequate DRs and accompanying
guidance; (ii) increase the number of dedicated microbiology
experts at responsible institutions; and (iii) ensure that the simpli-
fication offered by the (likely) categorization of MCAs as low-risk
‘substances’ is realized.
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